메뉴 건너뛰기




Volumn 111, Issue 1, 2014, Pages 409-414

Erratum: mTOR target NDRG1 confers MGMT-dependent resistance to alkylating chemotherapy (Proc. Natl. Acad. Sci. U.S.A. (2013) 111 (409–414) DOI:10.1073/pnas.1314469111);MTOR target NDRG1 confers MGMT-dependent resistance to alkylating chemotherapy

(28)  Weiler, Markus a,b   Blaes, Jonas a   Pusch, Stefan a,b   Sahm, Felix a,b   Czabanka, Marcus c   Luger, Sebastian a,b   Bunse, Lukas a,b   Solecki, Gergely a   Eichwald, Viktoria a   Jugold, Manfred a   Hodecker, Sibylle a,b   Osswald, Matthias a,b   Meisner, Christoph d   Hielscher, Thomas a   Rübmann, Petra a   Pfenning, Philipp Niklas a   Ronellenfitsch, Michael e   Kempf, Tore a   Schnölzer, Martina a   Abdollahi, Amir a,b   more..


Author keywords

[No Author keywords available]

Indexed keywords

ALKYLATING AGENT; CORTICOSTEROID; DEXAMETHASONE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MAMMALIAN TARGET OF RAPAMYCIN; MAMMALIAN TARGET OF RAPAMYCIN COMPLEX 2; METHYLATED DNA PROTEIN CYSTEINE METHYLTRANSFERASE; PROTEIN P53; SERUM AND GLUCOCORTICOID REGULATED KINASE 1; TEMOZOLOMIDE;

EID: 84891948402     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.2114464118     Document Type: Erratum
Times cited : (148)

References (23)
  • 1
    • 49649104978 scopus 로고    scopus 로고
    • Mechanisms of chemoresistance to alkylating agents in malignant glioma
    • Sarkaria JN, et al. (2008) Mechanisms of chemoresistance to alkylating agents in malignant glioma. Clin Cancer Res 14(10): 2900-2908.
    • (2008) Clin Cancer Res , vol.14 , Issue.10 , pp. 2900-2908
    • Sarkaria, J.N.1
  • 2
    • 84859847164 scopus 로고    scopus 로고
    • Emerging insights into the molecular and cellular basis of glioblastoma
    • Dunn GP, et al. (2012) Emerging insights into the molecular and cellular basis of glioblastoma. Genes Dev 26(8): 756-784.
    • (2012) Genes Dev , vol.26 , Issue.8 , pp. 756-784
    • Dunn, G.P.1
  • 3
    • 65649115060 scopus 로고    scopus 로고
    • Hypoxia helps glioma to fight therapy
    • Amberger-Murphy V (2009) Hypoxia helps glioma to fight therapy. Curr Cancer Drug Targets 9(3): 381-390.
    • (2009) Curr Cancer Drug Targets , vol.9 , Issue.3 , pp. 381-390
    • Amberger-Murphy, V.1
  • 4
    • 0036359548 scopus 로고    scopus 로고
    • Hypoxia-A key regulatory factor in tumour growth
    • Harris AL (2002) Hypoxia-A key regulatory factor in tumour growth. Nat Rev Cancer 2(1): 38-47.
    • (2002) Nat Rev Cancer , vol.2 , Issue.1 , pp. 38-47
    • Harris, A.L.1
  • 5
    • 19944422751 scopus 로고    scopus 로고
    • Kinetics of vascular normalization by VEGFR2 blockade governs brain tumor response to radiation: Role of oxygenation, angiopoietin-1, and matrix metalloproteinases
    • Winkler F, et al. (2004) Kinetics of vascular normalization by VEGFR2 blockade governs brain tumor response to radiation: Role of oxygenation, angiopoietin-1, and matrix metalloproteinases. Cancer Cell 6(6): 553-563.
    • (2004) Cancer Cell , vol.6 , Issue.6 , pp. 553-563
    • Winkler, F.1
  • 6
    • 0036703627 scopus 로고    scopus 로고
    • Hypoxic neuroprotection requires sequential activation of vascular endothelial growth factor receptor and Akt
    • Wick A, et al. (2002) Hypoxic neuroprotection requires sequential activation of vascular endothelial growth factor receptor and Akt. J Neurosci 22: 6401-6407.
    • (2002) J Neurosci , vol.22 , pp. 6401-6407
    • Wick, A.1
  • 7
    • 75149165633 scopus 로고    scopus 로고
    • Prolyl hydroxylases 2 and 3 act in gliomas as protective negative feedback regulators of hypoxia-inducible factors
    • Henze AT, et al. (2010) Prolyl hydroxylases 2 and 3 act in gliomas as protective negative feedback regulators of hypoxia-inducible factors. Cancer Res 70(1): 357-366.
    • (2010) Cancer Res , vol.70 , Issue.1 , pp. 357-366
    • Henze, A.T.1
  • 9
    • 78649813933 scopus 로고    scopus 로고
    • The N-myc downstream regulated gene (NDRG) family: Diverse functions, multiple applications
    • Melotte V, et al. (2010) The N-myc downstream regulated gene (NDRG) family: diverse functions, multiple applications. FASEB J 24(11): 4153-4166.
    • (2010) FASEB J , vol.24 , Issue.11 , pp. 4153-4166
    • Melotte, V.1
  • 10
    • 68949093646 scopus 로고    scopus 로고
    • Decreased expression of NDRG1 in glioma is related to tumor progression and survival of patients
    • Sun B, et al. (2009) Decreased expression of NDRG1 in glioma is related to tumor progression and survival of patients. J Neurooncol 94(2): 213-219.
    • (2009) J Neurooncol , vol.94 , Issue.2 , pp. 213-219
    • Sun, B.1
  • 11
    • 0036726313 scopus 로고    scopus 로고
    • Stable suppression of tumorigenicity by virus-mediated RNA interference
    • Brummelkamp TR, Bernards R, Agami R (2002) Stable suppression of tumorigenicity by virus-mediated RNA interference. Cancer Cell 2(3): 243-247.
    • (2002) Cancer Cell , vol.2 , Issue.3 , pp. 243-247
    • Brummelkamp, T.R.1    Bernards, R.2    Agami, R.3
  • 12
    • 84874739414 scopus 로고    scopus 로고
    • Suppression of proinvasive RGS4 by mTOR inhibition optimizes glioma treatment
    • Weiler M, et al. (2013) Suppression of proinvasive RGS4 by mTOR inhibition optimizes glioma treatment. Oncogene 32(9): 1099-1109.
    • (2013) Oncogene , vol.32 , Issue.9 , pp. 1099-1109
    • Weiler, M.1
  • 13
    • 77952571590 scopus 로고    scopus 로고
    • Phase II trial of radiochemotherapy with daily concomitant and adjuvant intensified (one week on / one week off) TMZ plus indomethacin in newly diagnosed glioblastoma: UKT-05
    • Weiler M, et al. (2010) Phase II trial of radiochemotherapy with daily concomitant and adjuvant intensified (one week on / one week off) TMZ plus indomethacin in newly diagnosed glioblastoma: UKT-05. Int J Rad Biol Phys 77(3): 670-676.
    • (2010) Int J Rad Biol Phys , vol.77 , Issue.3 , pp. 670-676
    • Weiler, M.1
  • 14
    • 73349134695 scopus 로고    scopus 로고
    • NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with procarbazine, lomustine, and vincristine or temozolomide
    • Wick W, et al. (2009) NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with procarbazine, lomustine, and vincristine or temozolomide. J Clin Oncol 27(35): 5874-5880.
    • (2009) J Clin Oncol , vol.27 , Issue.35 , pp. 5874-5880
    • Wick, W.1
  • 15
    • 84863091424 scopus 로고    scopus 로고
    • Temozolomide chemotherapy alone versus radiotherapy alone for malignant astrocytoma in the elderly: The NOA-08 randomised, phase 3 trial
    • NOA-08 Study Group of Neuro-oncology Working Group (NOA) of German Cancer Society
    • Wick W, et al.; NOA-08 Study Group of Neuro-oncology Working Group (NOA) of German Cancer Society (2012) Temozolomide chemotherapy alone versus radiotherapy alone for malignant astrocytoma in the elderly: The NOA-08 randomised, phase 3 trial. Lancet Oncol 13(7): 707-715.
    • (2012) Lancet Oncol , vol.13 , Issue.7 , pp. 707-715
    • Wick, W.1
  • 16
    • 35148883007 scopus 로고    scopus 로고
    • Egr-1 mediates hypoxia-inducible transcription of the NDRG1 gene through an overlapping Egr-1/Sp1 binding site in the promoter
    • Zhang P, Tchou-Wong KM, Costa M (2007) Egr-1 mediates hypoxia-inducible transcription of the NDRG1 gene through an overlapping Egr-1/Sp1 binding site in the promoter. Cancer Res 67(19): 9125-9133.
    • (2007) Cancer Res , vol.67 , Issue.19 , pp. 9125-9133
    • Zhang, P.1    Tchou-Wong, K.M.2    Costa, M.3
  • 17
    • 84862124600 scopus 로고    scopus 로고
    • NDRG1/Cap43/Drg-1 may predict tumor angiogenesis and poor outcome in patients with lung cancer
    • Azuma K, et al. (2012) NDRG1/Cap43/Drg-1 may predict tumor angiogenesis and poor outcome in patients with lung cancer. J Thorac Oncol 7(5): 779-789.
    • (2012) J Thorac Oncol , vol.7 , Issue.5 , pp. 779-789
    • Azuma, K.1
  • 18
    • 58649092475 scopus 로고    scopus 로고
    • MTOR complex 2 (mTORC2) controls hydrophobic motif phosphorylation and activation of serum- and glucocorticoid-induced protein kinase 1 (SGK1)
    • García-Martínez JM, Alessi DR (2008) mTOR complex 2 (mTORC2) controls hydrophobic motif phosphorylation and activation of serum- and glucocorticoid-induced protein kinase 1 (SGK1). Biochem J 416(3): 375-385.
    • (2008) Biochem J , vol.416 , Issue.3 , pp. 375-385
    • García-Martínez, J.M.1    Alessi, D.R.2
  • 19
    • 77952745809 scopus 로고    scopus 로고
    • Identification of sites subjected to serine/threonine phosphorylation by SGK1 affecting N-myc downstream-regulated gene 1 (NDRG1)/Cap43- dependent suppression of angiogenic CXC chemokine expression in human pancreatic cancer cells
    • Murakami Y, et al. (2010) Identification of sites subjected to serine/threonine phosphorylation by SGK1 affecting N-myc downstream-regulated gene 1 (NDRG1)/Cap43- dependent suppression of angiogenic CXC chemokine expression in human pancreatic cancer cells. Biochem Biophys Res Commun 396(2): 376-381.
    • (2010) Biochem Biophys Res Commun , vol.396 , Issue.2 , pp. 376-381
    • Murakami, Y.1
  • 20
    • 20044372154 scopus 로고    scopus 로고
    • MGMT gene silencing and benefit from temozolomide in glioblastoma
    • Hegi ME, et al. (2005) MGMT gene silencing and benefit from temozolomide in glioblastoma. N Engl J Med 352(10): 997-1003.
    • (2005) N Engl J Med , vol.352 , Issue.10 , pp. 997-1003
    • Hegi, M.E.1
  • 21
    • 84860816141 scopus 로고    scopus 로고
    • Oncogenic EGFR signaling activates an mTORC2-NF-κB pathway that promotes chemotherapy resistance
    • Tanaka K, et al. (2011) Oncogenic EGFR signaling activates an mTORC2-NF-κB pathway that promotes chemotherapy resistance. Cancer Discov 1(6): 524-538.
    • (2011) Cancer Discov , vol.1 , Issue.6 , pp. 524-538
    • Tanaka, K.1
  • 22
    • 58049216350 scopus 로고    scopus 로고
    • Differential dependence of hypoxia- inducible factors 1 alpha and 2 alpha on mTORC1 and mTORC2
    • Toschi A, Lee E, Gadir N, Ohh M, Foster DA (2008) Differential dependence of hypoxia- inducible factors 1 alpha and 2 alpha on mTORC1 and mTORC2. J Biol Chem 283(50): 34495-34499.
    • (2008) J Biol Chem , vol.283 , Issue.50 , pp. 34495-34499
    • Toschi, A.1    Lee, E.2    Gadir, N.3    Ohh, M.4    Foster, D.A.5
  • 23
    • 0035907309 scopus 로고    scopus 로고
    • Glucocorticoid receptor-mediated protection from apoptosis is associated with induction of the serine/threonine survival kinase gene, sgk-1
    • Mikosz CA, Brickley DR, Sharkey MS, Moran TW, Conzen SD (2001) Glucocorticoid receptor-mediated protection from apoptosis is associated with induction of the serine/threonine survival kinase gene, sgk-1. J Biol Chem 276(20): 16649-16654.
    • (2001) J Biol Chem , vol.276 , Issue.20 , pp. 16649-16654
    • Mikosz, C.A.1    Brickley, D.R.2    Sharkey, M.S.3    Moran, T.W.4    Conzen, S.D.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.